Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 95,730

Document Document Title
WO/2017/033188A1
Methods of producing algal oil and algal biofuel are provided. Accordingly there is provided a method of producing oil, the method comprising infecting Emiliania huxleyi microalgae with a Coccolithovirus Eh V201; and extracting the oil f...  
WO/2017/032739A1
The present invention relates to methods and pharmaceutical compositions for preventing or treating inflammatory bowel diseases.  
WO/2017/033965A1
Provided is a method for producing an aromatic compound, e.g., salicylic acid, and a derivative thereof with high productivity using a microorganism. Provided are: a method for producing a microorganism having a modified sugar metabolic ...  
WO/2017/029833A1
Provided is a method for site-specific insertion of a foreign DNA into an animal cell genome, said method comprising: (1) a step for constructing a donor plasmid in which 100-300 bp DNAs having a sequence homologous to an insertion site ...  
WO/2017/030503A1
The present invention relates to the field of fermentation biotechnology, more particularly to methods for the fermentative production of massoia lactone by Aureobasidium species.  
WO/2017/031277A1
Provided herein are methods for identifying and obtaining environmental isolates of microorganisms that maintain viability following seed treatment components or seed treatment processes and storage.  
WO/2017/030172A1
A neutral monoclonal antibody useful for effective antibody therapy against Ebola virus is needed. The present invention provides a monoclonal antibody or antigen-binding fragment thereof that is capable of recognizing the GP internal me...  
WO/2017/028040A1
The present invention provides a mycobacterium tuberculosis antigen for differentiating active tuberculosis with latent tuberculosis infection and applications thereof. Specifically, the present invention provides an immunogenic composit...  
WO/2017/030156A1
The present invention pertains to: a monoclonal antibody or a fragment thereof that includes at least one lysine derivative in the constant region of the human IgG antibody; a modified antibody or a fragment thereof in which the lysine d...  
WO/2017/029823A1
In this biological reaction device and this biological reaction method which uses said biological reaction device, a filter is used to separate a biological culture solution including micro-nanobubbles into a filtrate and a concentrate o...  
WO/2017/031211A1
This disclosure concerns compositions and methods for targeting peptides, polypeptides, and proteins to plastids of plastid-containing cells. In some embodiments, the disclosure concerns chloroplast transit peptides that may direct a pol...  
WO/2017/030457A1
The invention relates to the field of protecting plants against pests, and more particularly to a method of protecting plants against pests, which can be used for industrial and scientific purposes, in agriculture, horticulture and fo...  
WO/2017/028151A1
The present invention provides a composite microbial live bacterial agent for effectively degrading aniline in waste water, and a preparation method and application thereof. The composite microbial live bacterial agent comprises Acinetob...  
WO/2017/029733A1
In this biological reaction device and this biological reaction method which uses said biological reaction device, micro-nanobubbles (MNB) are included in a biological culture solution extracted from a culture tank, a filter is used to s...  
WO/2017/025586A1
The present disclosure relates to compositions and methods useful for the production of heterologous proteins in filamentous fungal cells.  
WO/2017/027568A1
The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making bacterial and viral vaccines.  
WO/2017/025648A1
A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 29 or an amino acid ...  
WO/2017/027821A1
Disclosed are methods for using rhizobial bacteria that are at least partially tolerant to multiple adverse environmental conditions to stimulate growth of plants grown under conditions that are not optimal for plant growth.  
WO/2017/026620A1
The present invention relates to: a Lactobacillus pentosus KF340 strain (deposit number KCCM 11675P); and a composition for preventing, alleviating, or treating Th1-mediated immune diseases, Th17-mediated immune diseases, or Th2-mediated...  
WO/2017/025339A1
The present invention relates to a new process of vanillin production from a substrate by bioconversion and that allows a continuously producing and removing vanillin from the fermentation broth as it is formed. In particular, the invent...  
WO/2017/026173A1
The purpose of the present invention is to provide a method for producing selenoneine with which it is possible to produce selenoneine on an industrial scale because selenoneine can be produced at a higher yield than in the prior art. Th...  
WO/2017/026593A1
The present invention relates to a livestock carcass disposal facility using aerobic thermophilic microorganisms and a burial disposal method. The present invention relates to a livestock carcass disposal facility and a burial disposal m...  
WO/2017/026532A1
The present invention relates to a method for separating cells capable of producing target antigen-specific monoclonal antibodies. In said method: a cell group including antibody-producing cells is immobilized using a crosslinking agent ...  
WO/2017/027490A1
Embodiments include a biological growth device, and related methods for growing biofilms using embodiments of such biological growth device. The device includes a channel configured to convey a fluid medium. A first coupon well is dispos...  
WO/2017/024372A1
The present invention relates to a method for producing a continuous cell line of embryonic-like stem cells, for example from Amblyomma sculptum (Acari: Ixodidae), designated as IBU/ASE-16 (access number in the CNCM: I-5000), and to the ...  
WO/2017/026635A1
The present invention relates to a composition for an animal feed comprising a Lactobacillus sp. strain or dead cells thereof, and a method for producing dead cells of the Lactobacillus sp. strain.  
WO/2017/027723A1
Disclosed herein are methods and compositions for the delivery of polypeptides, including vaccine candidate polypeptides, into mammalian cells comprising the use of photosensitized trypanosomatid organisms. Also disclosed are methods of ...  
WO/2017/026331A1
Provided is an active ingredient of a pharmaceutical composition for myeloma therapy. This antibody has an epitope in a region comprising the 20th to 109th amino acid residues of human integrin β7.  
WO/2017/025649A1
A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 35 or SEQ ID NO: 38 ...  
WO/2017/022740A1
A lipid production method for cultivating a transformant having enhanced expression of a gene encoding protein (A) or (B) below, and producing long-chain fatty acids or a lipid having the same as components. (A) Protein comprising an ami...  
WO/2017/024059A1
Disclosed herein are methods of terminally sterilizing bacterial niinicells or compositions comprising bacterial niinicells by exposure to ionizing irradiation. Also disclosed are terminally sterilized bacterial niinicells, pharmaceutica...  
WO/2017/022804A1
In order to provide a method whereby an olefin compound can be manufactured with high productivity and to provide an enzyme for use in the method, the inventors introduced variations involving amino acid substitution at various sites of ...  
WO/2017/023801A1
Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.  
WO/2017/021754A1
The present invention provides methods for the preparation of fermented food products comprising Bifidobacteria comprising the use of manganese. The present invention further provides products prepared by means of such a method as well a...  
WO/2017/022583A1
Provided is a promoter suitable for the high-level expression of a gene of interest. A promoter comprising DNA selected from the group consisting of DNA molecules (a) to (d): (a) DNA which comprises a nucleotide sequence represented by a...  
WO/2017/020785A1
An application of bacteroides fragilis in animal breeding, an application of the bacteroides fragilis in preventing and/or treating gastrointestinal diseases of animals, and an application thereof in pharmaceutical compositions and feed ...  
WO/2017/021931A1
The present invention falls within the field of biotechnologies and relates to a method for concentrating a cell suspension comprising a mucilaginous biomass of oleaginous yeasts. More specifically, the present invention relates to a met...  
WO/2017/020783A1
Provided is an application of bacteroides fragilis in prevention and/or treatment of meningitis, in particular, an application of the bacteroides fragilis in preparation of medicines, pharmaceutical compositions, food, health care produc...  
WO/2017/023070A1
The present invention relates to extracellular polysaccharides produced by Ceriporia lacerate, a mycelial culture broth of Ceriporia lacerate, containing the extracellular polysaccharides, a composition for promoting fatigue recovery con...  
WO/2017/023818A1
The present disclosure provides engineered bacterial cells comprising a heterologous gene encoding a propionate catabolism enzyme. In another aspect, the engineered bacterial cells further comprise at least one heterologous gene encoding...  
WO/2017/022587A1
A lipid production method for cultivating a transformant having enhanced expression of a gene encoding protein (A) or (B) below and producing fatty acids or a lipid having the same as structural components. (A) Protein comprising an amin...  
WO/2017/022856A1
The invention provides an alternative method for producing an isoprene monomer. Specifically, the present invention is a method for producing an isoprene monomer including the production of an isoprene monomer from dimethylallyl diphosph...  
WO/2017/022759A1
The present invention provides an antibody-binding protein having improved culture productivity in a genetic recombinant. The present invention relates to a protein that comprises two or more amino acid sequences derived from the E, D, A...  
WO/2017/020784A1
Provided are a bacteroides fragilis and an application thereof, and in particular, a bacteroides fragilis ZY-312 with a preservation number of CGMCC No. 10685, and an application of the bacteroides fragilis in preparation of medicines, p...  
WO/2017/024313A1
Disclosed are methods for producing steviol glycosides, such as rebaudioside D and rebaudioside M, using engineered yeast. The methods include growing yeast on non-fermentative carbon sources. Other methods include growing yeast on one o...  
WO/2017/020853A1
Disclosed is a solid state biological reaction device, comprising a main tank (1), wherein the device further comprises a support (2) supporting the main tank (1), and the support (2) makes the main tank (1) be rotational in the horizont...  
WO/2017/024059A8
Disclosed herein are methods of terminally sterilizing bacterial ninicells or compositions comprising bacterial ninicells by exposure to ionizing irradiation. Also disclosed are terminally sterilized bacterial ninicells, pharmaceutical c...  
WO/2017/020839A1
Provided are a heterologous expression and use of a good quality D-acetylglucosamine deacetylase. The D-acetylglucosamine deacetylase has an amino acid sequence as shown in SEQNO.1. An analysis on an assay on enzyme activity and substrat...  
WO/2017/022672A1
The purpose of the present invention is to provide an immunoglobulin-binding modified protein for the production of an affinity separation matrix having high antibody binding capacity. The present invention provides a protein that compri...  
WO/2017/019125A1
The present invention provides a protein material and food ingredient from a sustainable and stable source. The sustainable and stable source of the food or food ingredient is cellular biomass, for example an algal or microbial biomass. ...  

Matches 201 - 250 out of 95,730